Proposed Data Collection Submitted for Public Comment and Recommendations, 11446-11448 [2022-04192]
Download as PDF
<![CDATA[
11446
Federal Register / Vol. 87, No. 40 / Tuesday, March 1, 2022 / Notices
services are evaluated through their
multiple features or ‘attributes,’ and that
an individual’s choice of a product or
service is a function of the utility of
each attribute option or ‘level.’
Attributes and their corresponding
levels are chosen to represent the
features of medications, devices, and
healthcare services that are relevant to
a healthcare decision.
The proposed information collection
will include two separate DCE surveys:
One for priority populations and one for
clinicians. The survey uses an
experimental design to combine levels
from each attribute into hypothetical
product profiles and to pair profiles into
choice tasks. The experimental design
will be split into several blocks or
versions. Each equally sized block will
have 8–12 questions, and questions will
not be repeated across blocks.
Participants will be randomly assigned
to a block and will see only one block
when completing the survey instrument.
The study’s target population
includes persons ages 18 and older who
either (1) prescribe PrEP or (2) are in the
following priority population groups
selected because they have the highest
rates of HIV acquisition and are in need
for HIV prevention services:
• Gay, bisexual, and other men who
have sex with men subdivided by race/
ethnicity:
Æ Black/African American,
Æ Hispanic/Latino, or
Æ White;
• Black/African American
heterosexual persons subdivided by
biological sex:
Æ Men or
Æ Women;
• Transgender women; and
• Persons who inject drugs.
To be eligible for the study, potential
participants in each of the priority
population groups must be 18 years of
age or older, living without HIV, and
meet the U.S. Public Health Service
(USPHS) indications for offering PrEP as
described in the 2021 USPHS Clinical
Practice Guidelines.
The study sample will be recruited
from cities with high numbers of annual
HIV diagnoses within the 57 priority
jurisdictions identified as part of the
EHE initiative. Participants will be
randomly assigned to a block when they
are sent their unique DCE survey link
and will only complete the set of choice
tasks in that block. Throughout the
study, we will closely monitor
recruitment and data collection to
ensure that screening criteria are being
met, key demographic groups are
adequately represented, and survey
completion rates are acceptable.
Participation is voluntary. For this
study, CDC intends to screen
approximately 9,200 participants and
enroll 1,840 participants. CDC estimates
that approximately 15 percent of
enrolled participants will be removed
from the analysis due to fraud or
incomplete data, resulting in a final
analysis sample size of 1,600
participants. At 25 minutes per survey
and 10 minutes per combined screening
and consent, CDC requests approval for
an estimated 2,341 annualized burden
hours. There are no costs to respondents
other than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Average
burden per
response
(in hours)
Total burden
(in hours)
Form name
Black/African American, Hispanic/
Latino, or White men who are gay,
bisexual or have sex with men,
ages 18+ in the United States.
Black/African American Heterosexual
Cisgender Men or Women, ages
18+, in the United States.
Transgender Women, ages 18+, in
the United States.
Persons who inject drugs, ages 18+,
in the United States.
Clinical providers who prescribe
PrEP, in the United States.
Screening & Consent .......................
Survey ..............................................
3,450
690
1
1
10/60
25/60
587
290
Screening & Consent .......................
Survey ..............................................
2,300
460
1
1
10/60
25/60
391
194
Screening & Consent .......................
Survey ..............................................
Screening & Consent .......................
Survey ..............................................
Screening & Consent .......................
Survey ..............................................
1,150
230
1,150
230
1,150
230
1
1
1
1
1
1
10/60
25/60
10/60
25/60
10/60
25/60
196
97
196
97
196
97
Total ...........................................
...........................................................
........................
........................
........................
2,341
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–04190 Filed 2–28–22; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
BILLING CODE 4163–18–P
[60Day–22–1286; Docket No. CDC–2022–
0029]
jspears on DSK121TN23PROD with NOTICES1
Number of
responses
per
respondent
(Type of) respondents
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
AGENCY:
ACTION:
VerDate Sep<11>2014
19:01 Feb 28, 2022
Jkt 256001
PO 00000
Notice with comment period.
Frm 00052
Fmt 4703
Sfmt 4703
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled, Annual Reporting of the Rape
Prevention and Education (RPE)
Program. The RPE Program is the
principal federally funded program
focused on sexual violence (SV)
prevention. This data collection allows
SUMMARY:
E:\FR\FM\01MRN1.SGM
01MRN1
jspears on DSK121TN23PROD with NOTICES1
Federal Register / Vol. 87, No. 40 / Tuesday, March 1, 2022 / Notices
CDC to collect information about the
implementation and outcomes of CE19–
1902 cooperative agreement.
DATES: CDC must receive written
comments on or before May 2, 2022.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2022–
0029 by either of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
VerDate Sep<11>2014
19:01 Feb 28, 2022
Jkt 256001
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
Annual Reporting of the Rape
Prevention and Education (RPE)
Program (OMB Control No. 0920–1286,
Exp. 3/31/2023)—Revision—National
Center for Injury Prevention and Control
(NCIPC), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
This is a request for a Revision of the
currently approved Annual Reporting of
the Rape prevention and Education
(RPE) Program collection (OMB Control
No. 0920–1286, Exp. 03/31/2023). This
Revision is being requested to continue
to collect information related to
implementation and outcomes annually
from 53 recipients or their designated
delegates funded through the funding
opportunity, CE19–1902. Sexual
violence (SV) is a major public health
problem. One in three women and one
in four men experienced SV involving
physical contact during their lifetimes.
Nearly one in five women and one in 38
men have experienced completed or
attempted rape. SV starts early: One in
three female and one in four male rape
victims experienced it for the first time
between 11–17 years old. CDC’s
Division of Violence Prevention (DVP)
provides national leadership in
prevention of SV perpetration and
victimization before it begins (i.e.,
primary prevention). DVP administers
the RPE Program, which provides
funding to health departments in all 50
states, the District of Columbia (DC),
Puerto Rico, Guam, the U.S. Virgin
Islands, and the Commonwealth of
Northern Mariana Islands.
The RPE Program is the principal
federally funded program focused on SV
primary prevention. Collecting
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
11447
information about the implementation
and outcomes of CE19–1902 cooperative
agreement through the online data
system (DVP Partners Portal) is crucial
to informing SV prevention nationally;
enhancing accountability of the use of
federal funds; providing timely program
reports and responses to information
requests, such as Congressional requests
mandated by the authorizing legislation;
improving real-time communications
between CDC and RPE recipients; and
strengthening CDC’s capacity to provide
responsive data-driven technical
assistance and to monitor and evaluate
recipients’ progress and performance.
Information will be collected annually
from recipients through the DVP
Partners Portal. The DVP Partners Portal
is organized by forms, which are further
organized by sections and sub-sections.
Recipients and program staff are able to
review information reported in previous
years within the DVP Partners Portal per
their authenticated access. In addition,
information from previous reports will
be carried over and pre-populated for
the next annual reporting as
appropriate. Thus, with DVP Partners
Portal most of the burden is required
during the initial population of
information (Year 1), Recipients will
only need to enter changes, provide
progress information, and add new
information after Year 1.
CDC will use the information to be
collected for the following:
• Enhance accountability of the use of
federal funds
• Provide timely program reports and
responses to information request
• Improve real-time communications
between CDC and recipients
• Strengthen CDC’s capacity to provide
responsive and data-driven TA
• Strengthen CDC’s capacity to monitor
and evaluate recipients’ progress and
performance towards activities
required as part of the cooperative
agreement
• Allow both CDC and recipients to
track their own state activities and
outcomes, and ensure alignment
between their state and local activities
• Generate a variety of routine and
customizable reports specifically for
each recipient and in aggregate
nationally for CDC stakeholders
The total estimated annual burden for
this collection is 424 hours. CDC is
requesting a one-year approval. There is
no cost to respondents other than their
time.
E:\FR\FM\01MRN1.SGM
01MRN1
11448
Federal Register / Vol. 87, No. 40 / Tuesday, March 1, 2022 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Annual Reporting—Initial Population ......................
Annual Reporting—Subsequent Reporting .............
53
53
1
2
4
2
212
212
.................................................................................
....................
........................
....................
424
Form name
RPE-funded Health Departments (State, DC, and
Territories) and their Designated Delegates.
Total .................................................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
Prevention and the Agency for Toxic
Substances and Disease Registry.
Total
burden
(in hours)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP)—RFA–CK–22–
006, Clinical and Applied Research
Strategies for the Prevention and
Control of Fungal Diseases;
Cancellation of Meeting
Centers for Medicare & Medicaid
Services
McKesson, 7500 Security Boulevard,
Mail Stop: S3–02–01, Baltimore, MD
21244 or send via email to
MEDCACnomination@cms.hhs.gov.
FOR FURTHER INFORMATION CONTACT:
Ruth McKesson, MEDCAC Coordinator,
Centers for Medicare & Medicaid
Services, Center for Clinical Standards
and Quality, Coverage and Analysis
Group, S3–02–01, 7500 Security
Boulevard, Baltimore, MD 21244 or
contact Ms. McKesson by phone (410)
786–8611 or via email at
Ruth.McKesson@cms.hhs.gov.
SUPPLEMENTARY INFORMATION:
[CMS–3427–N]
I. Background
Medicare Program; Request for
Nominations for Members for the
Medicare Evidence Development &
Coverage Advisory Committee
The Secretary signed the initial
charter for the Medicare Coverage
Advisory Committee (MCAC) on
November 24, 1998. A notice in the
Federal Register (63 FR 68780)
announcing establishment of the MCAC
was published on December 14, 1998.
The MCAC name was updated to more
accurately reflect the purpose of the
committee and on January 26, 2007, the
Secretary published a notice in the
Federal Register (72 FR 3853),
announcing that the Committee’s name
changed to the Medicare Evidence
Development & Coverage Advisory
Committee (MEDCAC). The current
Secretary’s Charter for the MEDCAC is
available on the CMS website at: https://
www.cms.gov/Regulations-andGuidance/Guidance/FACA/Downloads/
medcaccharter.pdf or you may obtain a
copy of the charter by submitting a
request to the contact listed in the FOR
FURTHER INFORMATION section of this
notice.
The MEDCAC is governed by
provisions of the Federal Advisory
Committee Act, Public Law 92–463, as
amended (5 U.S.C. App. 2), which sets
forth standards for the formulation and
use of advisory committees, and is
authorized by section 222 of the Public
Health Service Act as amended (42
U.S.C. 217A).
We are requesting nominations for
candidates to serve on the MEDCAC.
Nominees are selected based upon their
individual qualifications and not solely
as representatives of professional
associations or societies. We wish to
[FR Doc. 2022–04192 Filed 2–28–22; 8:45 am]
BILLING CODE 4163–18–P
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2022–04259 Filed 2–28–22; 8:45 am]
Centers for Disease Control and
Prevention, Department of Health and
Human Services.
ACTION: Notice.
AGENCY:
Notice is
hereby given of a change in the meeting
of the Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP)—RFA–CK–22–
006, Clinical and Applied Research
Strategies for the Prevention and
Control of Fungal Diseases; April 14,
2022, 10:00 a.m.–5:00 p.m., EDT. The
teleconference was published in the
Federal Register on February 14, 2022,
Volume 87, Number 30, page 8251.
This meeting is being canceled in its
entirety.
FOR FURTHER INFORMATION CONTACT:
Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, CDC, National
Center for HIV, Viral Hepatitis, STD,
and TB Prevention, 1600 Clifton Road
NE, Mailstop US8–1, Atlanta, Georgia
30329, (404) 718–8833, ganderson@
cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
SUPPLEMENTARY INFORMATION:
jspears on DSK121TN23PROD with NOTICES1
Average
burden per
response
(in hours)
Number of
respondents
Type of respondents
VerDate Sep<11>2014
19:01 Feb 28, 2022
Jkt 256001
Centers for Medicare &
Medicaid Services, HHS.
ACTION: Notice.
AGENCY:
This notice announces the
request for nominations for membership
on the Medicare Evidence Development
& Coverage Advisory Committee
(MEDCAC). Among other duties, the
MEDCAC provides advice and guidance
to the Secretary of the Department of
Health and Human Services (the
Secretary) and the Administrator of the
Centers for Medicare & Medicaid
Services (CMS) concerning the
adequacy of scientific evidence
available to CMS in making coverage
determinations under the Medicare
program. The MEDCAC’s fundamental
purpose is to support the principles of
an evidence-based determination
process for Medicare’s coverage
policies. MEDCAC panels provide
advice to CMS on the strength of the
evidence available for specific medical
treatments and technologies through a
public, participatory, and accountable
process.
DATES: Nominations must be received
by Monday, March 28, 2022.
ADDRESSES: You may mail nominations
for membership to the following
address: Centers for Medicare &
Medicaid Services, Center for Clinical
Standards and Quality, Attention: Ruth
SUMMARY:
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
E:\FR\FM\01MRN1.SGM
01MRN1
]]>Agencies
[Federal Register Volume 87, Number 40 (Tuesday, March 1, 2022)]
[Notices]
[Pages 11446-11448]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-04192]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-22-1286; Docket No. CDC-2022-0029]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled, Annual Reporting of the Rape
Prevention and Education (RPE) Program. The RPE Program is the
principal federally funded program focused on sexual violence (SV)
prevention. This data collection allows
[[Page 11447]]
CDC to collect information about the implementation and outcomes of
CE19-1902 cooperative agreement.
DATES: CDC must receive written comments on or before May 2, 2022.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2022-
0029 by either of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS H21-8, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
Annual Reporting of the Rape Prevention and Education (RPE) Program
(OMB Control No. 0920-1286, Exp. 3/31/2023)--Revision--National Center
for Injury Prevention and Control (NCIPC), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
This is a request for a Revision of the currently approved Annual
Reporting of the Rape prevention and Education (RPE) Program collection
(OMB Control No. 0920-1286, Exp. 03/31/2023). This Revision is being
requested to continue to collect information related to implementation
and outcomes annually from 53 recipients or their designated delegates
funded through the funding opportunity, CE19-1902. Sexual violence (SV)
is a major public health problem. One in three women and one in four
men experienced SV involving physical contact during their lifetimes.
Nearly one in five women and one in 38 men have experienced completed
or attempted rape. SV starts early: One in three female and one in four
male rape victims experienced it for the first time between 11-17 years
old. CDC's Division of Violence Prevention (DVP) provides national
leadership in prevention of SV perpetration and victimization before it
begins (i.e., primary prevention). DVP administers the RPE Program,
which provides funding to health departments in all 50 states, the
District of Columbia (DC), Puerto Rico, Guam, the U.S. Virgin Islands,
and the Commonwealth of Northern Mariana Islands.
The RPE Program is the principal federally funded program focused
on SV primary prevention. Collecting information about the
implementation and outcomes of CE19-1902 cooperative agreement through
the online data system (DVP Partners Portal) is crucial to informing SV
prevention nationally; enhancing accountability of the use of federal
funds; providing timely program reports and responses to information
requests, such as Congressional requests mandated by the authorizing
legislation; improving real-time communications between CDC and RPE
recipients; and strengthening CDC's capacity to provide responsive
data-driven technical assistance and to monitor and evaluate
recipients' progress and performance.
Information will be collected annually from recipients through the
DVP Partners Portal. The DVP Partners Portal is organized by forms,
which are further organized by sections and sub-sections. Recipients
and program staff are able to review information reported in previous
years within the DVP Partners Portal per their authenticated access. In
addition, information from previous reports will be carried over and
pre-populated for the next annual reporting as appropriate. Thus, with
DVP Partners Portal most of the burden is required during the initial
population of information (Year 1), Recipients will only need to enter
changes, provide progress information, and add new information after
Year 1.
CDC will use the information to be collected for the following:
Enhance accountability of the use of federal funds
Provide timely program reports and responses to information
request
Improve real-time communications between CDC and recipients
Strengthen CDC's capacity to provide responsive and data-
driven TA
Strengthen CDC's capacity to monitor and evaluate recipients'
progress and performance towards activities required as part of the
cooperative agreement
Allow both CDC and recipients to track their own state
activities and outcomes, and ensure alignment between their state and
local activities
Generate a variety of routine and customizable reports
specifically for each recipient and in aggregate nationally for CDC
stakeholders
The total estimated annual burden for this collection is 424 hours.
CDC is requesting a one-year approval. There is no cost to respondents
other than their time.
[[Page 11448]]
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total
Type of respondents Form name respondents responses per response burden (in
respondent (in hours) hours)
----------------------------------------------------------------------------------------------------------------
RPE-funded Health Departments Annual Reporting-- 53 1 4 212
(State, DC, and Territories) and Initial Population. 53 2 2 212
their Designated Delegates. Annual Reporting--
Subsequent Reporting.
------------------------------------------------------
Total......................... ..................... ........... .............. ........... 424
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2022-04192 Filed 2-28-22; 8:45 am]
BILLING CODE 4163-18-P
